|
|
|
Volumn 24, Issue SUPPL. 1, 2001, Pages 1-5
|
|
Tumor angiogenesis: New approaches to cancer therapy;Tumorangiogenese: Neue ansätze zur krebstherapie
|
|
Author keywords
Angiopoietin; Tumor angiogenesis; Tyrosin kinase inhibitor; Vascular endothelial growth factor (VEGF)
|
|
Indexed keywords
3 [(4,5 DIMETHYL 1H PYRROL 2 YL)METHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE;
ANGIOGENESIS INHIBITOR;
ANGIOGENIC FACTOR;
ANGIOPOIETIN 1;
ANGIOPOIETIN 2;
ANGIOPOIETIN RECEPTOR;
CILENGITIDE;
MONOCLONAL ANTIBODY LM 609;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
VASCULOTROPIN ANTIBODY;
VASCULOTROPIN RECEPTOR;
VASCULOTROPIN RECEPTOR 1;
VATALANIB;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INHIBITION;
CLINICAL TRIAL;
HUMAN;
HUMAN CELL;
MELANOMA CELL;
METASTASIS;
MONOTHERAPY;
MOUSE;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
REVIEW;
SOLID TUMOR;
TUMOR VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANGIOPOIETIN-2;
ANIMALS;
HUMANS;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, NUDE;
NEOPLASM PROTEINS;
NEOPLASM TRANSPLANTATION;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
PROTEINS;
PROTO-ONCOGENE PROTEINS;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTOR, TIE-2;
RECEPTORS, GROWTH FACTOR;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
SIGNAL TRANSDUCTION;
|
|
EID: 17144452362
PISSN: 0378584X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (4)
|
